STAT3 and B-cell chronic lymphocytic leukemia: Lenalidomide has been shown to reverse the T cell exhaustion by inhibiting IL-10-induced STAT3 (signal transducer and activator of transcription 3) phosphorylation in patients with chronic lymphocytic leukemia (CLL) [69].